Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer
Go back to Tenax Therapeutics Appoints Thomas R. Staab, II as Chief Financial Officer| (NASDAQ: TENX) | Delayed: 1.85 -0.06 (3.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.91 | 52 Week High | $3.40 | |||
| Open | $1.91 | 52 Week Low | $1.34 | |||
| Day High | $1.91 | P/E | N/A | |||
| Day Low | $1.84 | EPS | $0.00 | |||
| Volume | 375,287 | |||||



